M Tempero

Margaret Tempero 3 collaborations

Lawrence Fong 2 collaborations

J Tabernero 2 collaborations

Meenal Sinha 1 collaboration

Courtney Betts 1 collaboration

Li Zhang 1 collaboration

Madeline J Griffith 1 collaboration

Isabelle Solman 1 collaboration

Brandon Chen 1 collaboration

Eric Liu 1 collaboration

Whitney Tamaki 1 collaboration

Jacob Stultz 1 collaboration

Jaqueline Marquez 1 collaboration

Shamilene Sivagnanam 1 collaboration

Alexander Cheung 1 collaboration

Denise Pener 1 collaboration

Anne Fahlman 1 collaboration

Erin Taber 1 collaboration

Kimberly Lerner 1 collaboration

Matthew Crocker 1 collaboration

Kendra Todd 1 collaboration

Brindha Rajagopalan 1 collaboration

Clarisha Ware 1 collaboration

Mark Bridge 1 collaboration

Johnson Vo 1 collaboration

Hannah Dragomanovich 1 collaboration

Julie Sudduth-Klinger 1 collaboration

Gina Vaccaro 1 collaboration

Charles D Lopez 1 collaboration

Lisa M Coussens 1 collaboration

Andrew H Ko 1 collaboration

Alexander C Jordan 1 collaboration

Evan Tooker 1 collaboration

Simon F Lacey 1 collaboration

Renee B Chang 1 collaboration

Yan Li 1 collaboration

Alan P Venook 1 collaboration

Lloyd Damon 1 collaboration

Mark H O'Hara 1 collaboration

Bruce L Levine 1 collaboration

J Joseph Melenhorst 1 collaboration

Gabriela Plesa 1 collaboration

Carl H June 1 collaboration

Gregory L Beatty 1 collaboration

C Sessa 1 collaboration

J Cortes 1 collaboration

P Conte 1 collaboration

F Cardoso 1 collaboration

T Choueiri 1 collaboration

R Dummer 1 collaboration

P Lorusso 1 collaboration

O Ottmann 1 collaboration

B Ryll 1 collaboration

T Mok 1 collaboration

S Comis 1 collaboration

C Oliva 1 collaboration

S Peters 1 collaboration

D-Y Oh 1 collaboration

M Reni 1 collaboration

E Van Cutsem 1 collaboration

A Hendifar 1 collaboration

D-T Waldschmidt 1 collaboration

N Starling 1 collaboration

J-B Bachet 1 collaboration

H-M Chang 1 collaboration

J Maurel 1 collaboration

R Garcia-Carbonero 1 collaboration

S Lonardi 1 collaboration

L M Coussens 1 collaboration

L Fong 1 collaboration

L C Tsao 1 collaboration

G Cole 1 collaboration

D James 1 collaboration

T Macarulla 1 collaboration

Michele Reni 1 collaboration

Julia Braverman 1 collaboration

Andrew Hendifar 1 collaboration

Chung-Pin Li 1 collaboration

Teresa Macarulla 1 collaboration

Do-Youn Oh 1 collaboration

Hanno Riess 1 collaboration

Brian Lu 1 collaboration

James Marcus 1 collaboration

Namita Joshi 1 collaboration

Marc Botteman 1 collaboration

Amylou C Dueck 1 collaboration

T Seufferlein 1 collaboration

W Uhl 1 collaboration

M Kornmann 1 collaboration

H Algül 1 collaboration

H Friess 1 collaboration

A König 1 collaboration

M Ghadimi 1 collaboration

E Gallmeier 1 collaboration

D K Bartsch 1 collaboration

M P Lutz 1 collaboration

R Metzger 1 collaboration

K Wille 1 collaboration

B Gerdes 1 collaboration

C C Schimanski 1 collaboration

F Graupe 1 collaboration

V Kunzmann 1 collaboration

I Klein 1 collaboration

M Geissler 1 collaboration

L Staib 1 collaboration

D Waldschmidt 1 collaboration

C Bruns 1 collaboration

U Wittel 1 collaboration

S Fichtner-Feigl 1 collaboration

S Daum 1 collaboration

A Hinke 1 collaboration

L Blome 1 collaboration

A Tannapfel 1 collaboration

A Kleger 1 collaboration

A W Berger 1 collaboration

A M R Kestler 1 collaboration

J S Schuhbaur 1 collaboration

L Perkhofer 1 collaboration

A C Reinacher-Schick 1 collaboration

T J Ettrich 1 collaboration

Affiliations

Publications (6)

Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma.

Dual Targeting of Mesothelin and CD19 with Chimeric Antigen Receptor-Modified T Cells in Patients with Metastatic Pancreatic Cancer.

The impact of COVID-19 on cancer care and oncology clinical research: an experts' perspective.

Ibrutinib in combination with nab-paclitaxel and gemcitabine for first-line treatment of patients with metastatic pancreatic adenocarcinoma: phase III RESOLVE study.

Evaluation of Minimal Important Difference and Responder Definition in the EORTC QLQ-PAN26 Module for Assessing Health-Related Quality of Life in Patients with Surgically Resected Pancreatic Adenocarcinoma.

Perioperative or only adjuvant gemcitabine plus nab-paclitaxel for resectable pancreatic cancer (NEONAX)-a randomized phase II trial of the AIO pancreatic cancer group.

Réseau de co-auteurs